A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04). (Q41244434)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04). |
scientific article |
Statements
1 reference
A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04). (English)
1 reference
Lee DJ
1 reference
Pajak TF
1 reference
Stetz J
1 reference
Order SE
1 reference
Weissberg JB
1 reference
Fischer JJ
1 reference
1 February 1989
1 reference
1 reference
16
1 reference
2
1 reference
465-470
1 reference
Identifiers
1 reference